A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2018
At a glance
- Drugs Escitalopram (Primary) ; Venlafaxine (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Proof of concept; Therapeutic Use
- 19 Oct 2018 Planned End Date changed from 1 Jul 2019 to 1 Jan 2019.
- 19 Oct 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jan 2019.
- 12 Sep 2017 New trial record